JWH-047
JWH-047 is a synthetic cannabinoid from the naphthoylindole family. It acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with a binding affinity of 9.0 nM at CB1 and 2.94 nM at CB2. JWH-047 is one of the few synthetic cannabinoids to feature a 2'-naphthoyl group, and is structurally somewhat similar to other naphthoylindole cannabinoids such as JWH-018 and JWH-073.
Chemistry[edit | edit source]
JWH-047 is a member of the naphthoylindole family of synthetic cannabinoids. It is structurally similar to other members of this family, such as JWH-018 and JWH-073, but features a 2'-naphthoyl group, which is relatively rare among synthetic cannabinoids.
Pharmacology[edit | edit source]
JWH-047 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It has a binding affinity of 9.0 nM at CB1 and 2.94 nM at CB2. The effects of JWH-047 on the human body are not well-studied, and its toxicity and potential for abuse are unknown.
Legal Status[edit | edit source]
The legal status of JWH-047 varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other synthetic cannabinoids, while in others it is legal to possess and sell.
See Also[edit | edit source]
JWH-047 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD